INA is a novel NEN biomarker, and its expression was associated with MAPK signaling and proliferation.
In clinical samples, elevated INA was correlated with Ki-67 and identified malignancy. INA may provide additional biologic information relevant to delineation of both pancreatic NEN tumor phenotypes and clinical behavior.
2012-05-04
Eng.
Cancer
Department of Gastroenterological Surgery, Yale University School of Medicine, New Haven, CT, USA.
Cancer. 2012 May;118(10):2763-75
© Galenicom 1999-2013